The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

Schizophrenia | Delusional Disorder | Psychosis of Alzheimer’s Disease | Psychosis in Mild Cognitive Impairment | Psychosis in Parkinson’s Disease | Psychosis in Other Major Neurocognitive Disorders | Treatment | Conclusion | References

Excerpt

Delusions, hallucinations, and other psychotic symptoms can accompany a variety of conditions in late life. These symptoms may be more common than previously thought; Swedish investigators found that in a sample of individuals age 85 years, the prevalence of psychotic symptoms was 10.1%, with 6.9% of subjects having hallucinations, 5.5% having delusions, and 6.9% having paranoid ideation (Östling and Skoog 2002). Conditions causing acute psychotic symptoms that tend to resolve when the underlying condition is treated are discussed elsewhere in this textbook (e.g., delirium in Chapter 7, “Delirium,” and drug-induced psychosis in Chapter 20, “Psychopharmacology”). In this chapter, we review the epidemiology, presentation, and treatment of chronic late-life psychotic disorders that are not secondary to a mood disorder or a general medical condition other than a neurocognitive disorder. These include early-onset schizophrenia, late-onset schizophrenia, very-late-onset schizophrenia-like psychosis (VLOSLP; onset after age 60 years), delusional disorder, and psychosis related to a major neurocognitive disorder such as Alzheimer’s disease (AD).

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).